Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-17T07:23:23.709Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinical State, Plasma Levels of Haloperidol and Prolactin: A Correlation Study in Chronic Schizophrenia

Published online by Cambridge University Press:  29 January 2018

V. A. Rama Rao ,
Margaret Bishop  and
Alec Coppen
V. A. Rama Rao
Affiliation:
All Saints' Hospital, Chatham, Kent, and Guy's Hospital Medical School, London SE1
Margaret Bishop
Affiliation:
MRC Neuropsychiatry Laboratory, West Park Hospital, Epsom, Surrey KT19 8PB
Alec Coppen
Affiliation:
MRC Neuropsychiatry Laboratory, West Park Hospital, Epsom, Surrey KT19 8PB
Get access Rights & Permissions [Opens in a new window]

Summary

Chronic schizophrenic patients were maintained for six months on a dosage of haloperidol adjusted to give optimum clinical effect. A correlation was found between extrapyramidal symptoms and prolactin levels and also between plasma haloperidol concentration and plasma prolactin levels. Estimation of plasma prolactin would be a reliable measurement of patients' compliance with medication.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 137 , Issue 6 , December 1980 , pp. 518 - 521
Copyright
Copyright © Royal College of Psychiatrists, 1980 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ayd, F. (1972) Haloperidol. Fifteen years of clinical experience. Diseases of the Nervous System, 33, 459–469.Google Scholar
Clarke, B. R. Tower, B. B. Rubin, R. T. et al (1977) A Radioimmunoassay of haloperidol in human serum. Life Sciences, 20, 319–326.CrossRefGoogle Scholar
Ericksen, S. E. Hurt, S. W. & Chang, S. (1978) Haloperidol dose, plasma levels and clinical response. Psychopharmacology Bulletin, 14, 2, 15–16.Google Scholar
Frantz, A. G. (1973) Catecholomines and the control of prolactin secretion in humans. In Progress in Brain Research, Drug Effects on Neuroendocrine Regulation, eds. Zimmerman, E. Gispen, W. H. and DeWeid, D.). London: Elsevier, pp 311.CrossRefGoogle Scholar
Fuxe, K. & Hokfelt, T. (1966) Further evidence for tuberoinfundibular dopamine neurones. Acta Physiologica Scandinavica, 66, 245–246.Google Scholar
Ghose, K. (1977) Lithium salts: Therapeutic and unwanted effects. British Journal of Hospital Medicine, 18, 578–583.Google Scholar
Gruen, P. H. Sachar, E. J. Langer, G. Altman, N. Leifer, M. Frantz, A. & Halpern, F. S. (1978) Prolactin responses to neuroleptics in normal and schizophrenic subjects. Archives of General Psychiatry, 35, 106–116.Google Scholar
Howard, J. S. & Schmidt, K. T. (1973) End of back ward: The rapid rehabilitation and release of chronically hospitalized psychiatric patients. Psychosomatics, 14.Google Scholar
Iversen, L. (1975) Dopamine receptors in brain. Science, 188, 1084–1089.CrossRefGoogle Scholar
Man, O. L. & Chen, C. H. (1973) Rapid medication of acutely psychotic patients with intramuscular haloperidol and chlorpromazine. Psychosomatics, 14, 59–63.Google Scholar
McCreadie, R. G. & MacDonald, I. M. (1977) High dosage haloperidol in chronic schizophrenia. British Journal of Psychiatry, 131, 310–316.Google Scholar
Michaels, M. Hendricks, R. & Heykants, J. (1976) Antibodies to haloperidol: A very sensitive tool for the radioimmunologic determination of some butyrophenones. Jansen Pharmaceutica Research Report, R/1625/2.Google Scholar
O'Keeffe, R. Sharman, D. F. & Vogt, M. (1970) Effect of drugs used in psychoses on cerebral dopamine metabolism. British Journal of Pharmacology, 38, 287–304.Google Scholar
Oldham, A. J. & Bott, M. (1977) The management of excitement in a general hospital psychiatric ward by high dosage haloperidol. Acta Psychiatrica Scandinavica, 47, 369–376.Google Scholar
Overall, J. E. & Gorham, D. R. (1962) The brief psychiatric rating scale. Psychological Reports, 10, 799–812 (1962).CrossRefGoogle Scholar
Reschke, R. W. (1974) Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia. Diseases of the Nervous System, 35, 112–115.Google Scholar
Snyder, S. H. Taylor, K. M. & Coyle, J. T. (1970) The role of brain dopamine in behavioural regulation and the actions of psychotropic drugs. American Journal of Psychiatry, 127, 119–207.Google Scholar
Snyder, S. H. Banerjee, S. P. Yamamuro, H. I. et al (1974) Drugs, neurotransmitters and schizophrenia. Science, 184, 1243–1253.Google Scholar
Wind, J. K. (1961) A simple and reliable sub-classification of chronic schizophrenia. Journal of Mental Science, 107, 862–875.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.